| Dr Ronald Wolz Kelly, MD | |
|
12a Ledgebrook Dr, Mansfield Center, CT 06250-1664 | |
| (860) 423-2960 | |
| (860) 423-3719 |
| Full Name | Dr Ronald Wolz Kelly |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 12a Ledgebrook Dr, Mansfield Center, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760430110 | NPI | - | NPPES |
| 001207612 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 020761 (Connecticut) | Primary |
| Entity Name | Generations Family Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228905 PECOS PAC ID: 4880640630 Enrollment ID: O20050324000979 |
News Archive
Neogenix Oncology, Inc. (Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer.
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
If mice grow up in a stimulating environment, for example in large cages with running wheels and labyrinths with several other mice, their brain remains adaptable for longer, ie more plastic. In fact, not only these mice, but also their offspring, benefit from this enrichment.
Endo Pharmaceuticals has announced that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Wolz Kelly, MD 12a Ledgebrook Dr, Mansfield Center, CT 06250-1664 Ph: (860) 423-2960 | Dr Ronald Wolz Kelly, MD 12a Ledgebrook Dr, Mansfield Center, CT 06250-1664 Ph: (860) 423-2960 |
News Archive
Neogenix Oncology, Inc. (Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer.
When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.
If mice grow up in a stimulating environment, for example in large cages with running wheels and labyrinths with several other mice, their brain remains adaptable for longer, ie more plastic. In fact, not only these mice, but also their offspring, benefit from this enrichment.
Endo Pharmaceuticals has announced that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.
› Verified 8 days ago
Suzanne M Powell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12a Ledgebrook Dr, Mansfield Center, CT 06250 Phone: 860-423-2960 Fax: 860-423-3719 | |
Dr. Craig Russell Elliott, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12a Ledgebrook Dr, Mansfield Center, CT 06250 Phone: 860-423-2960 Fax: 860-423-3719 | |
Dr. Anne Schwirck Willenborg, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12a Ledgebrook Dr, Mansfield Center, CT 06250 Phone: 860-423-2960 Fax: 860-423-3719 | |
Dr. Thomas Harrison Gorin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12a Ledgebrook Dr, Mansfield Center, CT 06250 Phone: 860-423-2960 Fax: 860-423-3719 |